Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Setting

Presley C, Tang D, Soulos P, Chiang A, Longtine J, Adelson K, Herbst R, Zhu W, Nussbaum N, Sorg R, Agarwala V, Abernethy AP, Gross C

August 2018

Manuscript

JAMA

Flatiron-authored

Comparative Effectiveness from a Single-Arm Trial and Real-World Data: Alectinib versus Ceritinib

Davies J, Martinec M, Delmar P, Coudert M, Bordogna W, Golding S, Reynaldo M, Crane G

June 2018

Manuscript

Future Medicine

Development and Validation of a High-Quality Composite Real-World Mortality Endpoint

Curtis MD, Griffith S, Tucker M, Taylor M, Capra W, Carrigan G, Holzman B, Torres AZ, You P, Arnieri B, Abernethy AP

June 2018

Abstract

Academy Health Annual Research Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

Real-world Data (RWD) on Tumor Response (rwTR) in Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients Receiving Cancer Immunotherapy and Targeted Therapies

Lu M, Sadetsky N, Lambert P, Whipple S, Taylor M, Riehl T, Riely GJ

June 2018

Abstract

ASCO Annual Meeting

Risk Stratification Using Patient-Reported Outcomes (PROs) in Patients (pts) with Advanced Cancer

Patel SB, Haaland B, Ose D, Haydell T, Martineau J, Dunson W, Chalmers AW, Cannon L, Kissell B, Meropol N, Akerley W

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Development of a Dashboard for End-of-Life Care at an Academic Hospital

Adelson K, Meropol N, Hamrick HJ, Haydell T, Martineau J, Kraut J, Severino KM, Lilenbaum R

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Age-Related Real-World Outcomes for Patients (pts) with Metastatic Colorectal Cancer (mCRC)

Curtis MD, Nussbaum N, Hamrick HJ, Bennette CS, Meropol N, Miksad RA

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Real World Outcomes of Metastatic Pancreatic Cancer (mPC) Patients (pts) Treated with Liposomal Irinotecan (nal-IRI) in the US

Barzi A, Miksad RA, Surinach A, Corvino F, Wang S, Torres AZ, Mamlouk KK, Pulgar SJ, Bekaii-Saab TS

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Sequencing of Ramucirumab (ram) and Immune Checkpoint Inhibitors (ICIs) in Platinum (Pt)-Treated Real-World Patients (pts) with Advanced Non-Small Cell Lung Cancer (aNSCLC)

Clarke JM, Molife C, Miksad RA, Batus M, Winfree KB, Gossai A, Stefaniak VJ, Foster R, Cui Z, Torres AZ, Feuchtbaum D, Tawney MK, Bonomi PD

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Identifying the Prognostic Significance of Genomic Alterations in a Real-World, EHR-Derived Clinico-Genomic Database (CGDB)

Agarwala V, Backenroth D, Singal G, O'Connell C, Li G, Alpha-Cobb G, Kaushik G, Carson K, Miller V, Abernethy AP

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

Prevalence of Microsatellite Instability and Association with Pembrolizumab (P) Usage in a Real-World Clinico-Genomic Database

O'Connell C, Backenroth D, Singal G, Agarwala V, Li G, Kaushik G, Alpha-Cobb G, Kao CK, Miller V, Abernethy AP, Carson K

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

June 2018

Abstract

ASCO Annual Meeting

Flatiron-authored

ICD-Coded Information on Sites of Metastasis in Oncology Real-World Data is Specific But Not Sensitive

Parrinello CM, Seidl-Rathkopf K, Bennette CS, Bourla A, Nussbaum N, Carson K, Abernethy AP

May 2018

Abstract

ISPOR Annual Meeting

Flatiron-authored

May 2018

Abstract

ISPOR Annual Meeting

Flatiron-authored

May 2018

Abstract

Academy Health Annual Research Meeting

Flatiron-authored

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint

Curtis MD, Griffith S, Tucker M, Taylor M, Capra W, Carrigan G, Holzman B, Torres AZ, You P, Arnieri B, Abernethy AP

May 2018

Manuscript

Health Services Research

Flatiron-authored

Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials

O’Connor J, Fessele K, Steiner J, Seidl-Rathkopf K, Carson K, Nussbaum N, Yin E, Adelson K, Presley C, Chiang A, Ross J, Abernethy AP, Gross C

May 2018

Manuscript

JAMA Oncology

Flatiron-authored

Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study

Agarwala V, Khozin S, Singal G, O'Connell C, Kuk D, Li G, Gossai A, Miller V, Abernethy AP

May 2018

Manuscript

Health Affairs

Flatiron-authored

Identification of Resistance Mechanisms to EGFR Treatment in the Real World Using a Clinicogenomic Database

Singal G, Agarwal A, Kaushik G, O'Connell C, Alpha-Cobb G, Caron T, Bourque D, Guria A, Frank S, Frampton G, Carson K, Abernethy AP, Miller V

April 2018

Abstract

American Association for Cancer Research Annual Meeting

Flatiron-authored

Use of Cancer Immunotherapies in the Real-World in the Setting of Microsatellite Instability

Agarwala V, Gossai A, Singal G, O'Connell C, Li G, Kao K, Bourque D, Feuchtbaum D, Nunnally A, Frampton G, Ali S, Abernethy AP, Kramarz S, Trabucco SE

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

Flatiron-authored

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

January 2018

Abstract

ASCO-SITC Clinical Immuno-Oncology Symposium

January 2018

Abstract

ASCO Gastrointestinal Cancers Symposium

Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval

Khozin S, Abernethy AP, Nussbaum N, Zhi J, Curtis MD, Tucker M, Lee S, Light D, Gossai A, Sorg R, Torres AZ, Patel P, Blumenthal G, Pazdur R

January 2018

Manuscript

The Oncologist

Flatiron-authored

Treatment Dynamics of Bone-Targeting Agents Among Men with Bone Metastases from Prostate Cancer in the United States

Butler A, Cetin K, Hernandez RK, Reams D, Overman R, Kim J, Hirsch B, Abernethy AP, Liede A, Brookhart A

January 2018

Manuscript

Pharmacoepidemiology & Drug Safety

Flatiron-authored

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Annual Meeting

December 2017

Abstract

American Society of Hematology Oncology

December 2017

Manuscript

Clinical Pharmacology and Therapeutics

Flatiron-authored

December 2017

Abstract

San Antonio Breast Cancer Symposium

Treatment Patterns for Young Women with HR+/HER2- Metastatic Breast Cancer in the United States in the Era of CDK 4/6 Inhibitors

Burstein H, Mayer E, DeMichele A, Harnett J, Mardekian J, McRoy L, Huang Bartlett C, Koehler M, Fahed Rimawi M

December 2017

Abstract

San Antonio Breast Cancer Symposium